IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM (SIE 2025) - Oct 27, 2025 - Abstract #DP042; Pres time: Oct 20, 2025; 07:00 PM - 08:00 PM; Location: ROOM 2; "As GVHD prophylaxis, all received CSA, MMF, and PT-Cy 50 mg/kg for 2 days and 94.5% (n=34, CMV+) received letermovir,as CMV prophylaxis...Anidulafungin-related toxicity was observed in 36.1% (n=13) of patients, exclusively as liver WHO grading <2 and resolved within 3 days of stopping the drug...1 year NRM Months Cumulative Risk Figure 1. 100 days and 1 year NRM."
Clinical • Acute Graft versus Host Disease • Bone Marrow Transplantation • Chronic Graft versus Host Disease • Graft versus Host Disease • Immunology • Infectious Disease • Transplantation
|
|
A. Carobene 1; M. Pedata 1; M. Celentano 1; T. Ascione 1; C. Riccardi 1; S. Marotta 1; S. Leone 1; I. Migliaccio 1; C. Luise 1; U. De Martino 2; V. Oliva 1; S.M. Muggianu 1; M. Boccola 1; D. Buonanno 1; C. Falco 3; L. Altomare 3; A. Zuccarelli 3; M. Toriello 4; R. Penta 4; A. Picardi 1
|